Reversible palpebral ptosis following oxaliplatin infusion.
La Verde
N
N
Garassino
M C
MC
Spinelli
G
G
Scanni
A
A
Sburlati
P
P
Farina
G
G
Labianca
R
R
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001763:Blepharoptosis / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008875:Middle Aged; D020258:Neurotoxicity Syndromes / Q000209:etiology* / Q000503:physiopathology; D009944:Organoplatinum Compounds / Q000009:adverse effects*; D000077150:Oxaliplatin
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin